These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7386475)

  • 1. Qaulity-control plan for intravenous admixture programs. II: Validation of operator technique.
    Morris BG; Avis KE; Bowles GC
    Am J Hosp Pharm; 1980 May; 37(5):668-72. PubMed ID: 7386475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures.
    Sanders LH; Mabadeje SA; Avis KE; Cruze CA; Martinez DR
    Am J Hosp Pharm; 1978 May; 35(5):531-6. PubMed ID: 350042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M; Sanborn MD; Couldry R
    Am J Health Syst Pharm; 2005 Nov; 62(22):2386-92. PubMed ID: 16278330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 10. Cumulative sum control charts for admixture quality control.
    Sanford RL
    Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses.
    Austin P; Elia M
    J Hosp Infect; 2013 Feb; 83(2):160-3. PubMed ID: 23313030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first-phase quality assurance program for intravenous admixture aseptic technique.
    Gurwich EL; Hanold L; Schaeffer P
    Hosp Pharm; 1982 Mar; 17(3):119-21. PubMed ID: 10255637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aseptic simulation test challenged with microorganisms for validation of pharmacy operators.
    Sigward E; Fourgeaud M; Vazquez R; Guerrault-Moro MN; Brossard D; Crauste-Manciet S
    Am J Health Syst Pharm; 2012 Jul; 69(14):1218-24. PubMed ID: 22761076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

  • 18. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
    Trissel LA; Gentempo JA; Anderson RW; Lajeunesse JD
    Am J Health Syst Pharm; 2005 Feb; 62(3):285-8. PubMed ID: 15719586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assuring the quality of intravenous admixture programs.
    Stolar MH
    Am J Hosp Pharm; 1979 May; 36(5):605-8. PubMed ID: 453213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.